Search

Despite the vast literature on postpartum mastitis in cattle, there is a demand for and lack of studies on the cellularity dynamics and cellular populations in milk and the occurrence of mastitis in ewes during the postpartum period. Thus, the aim of the present study was to evaluate the dynamics of cellularity in milk/colostrum and of mastitis in primiparous and multiparous Lacaune ewes during early lactation. For this purpose, 492 milk/colostrum samples were collected from the udder halves of 20 primiparous ewes and 21 multiparous ewes at the following six time points: day of parturition (T1) and one day (T2), three days (T3), seven days (T4), 15 days (T5), and 30 days (T6) after parturition. The milk and colostrum samples were subjected to microbiological examination, microscopic and automatic somatic cell counts (SCCs), differential somatic cell counts, and the California Mastitis test (CMT). The multiparous ewes had a higher prevalence of intramammary infections than the primiparous ewes during the postpartum period. Non-aureus staphylococci bacteria were the main mastitis etiological agents isolated in the present study. Furthermore, one of the most important findings of our study was that 35% of the udder halves of the primiparous ewes were infected at parturition, suggesting potential concerns for mastitis control programs. Finally, the SCC did not appear to be a good indicator of inflammation during early lactation because this measure was influenced by the parity and the sampling period. Moreover, the predictive values of the CMT and neutrophil counts were slightly better than those of the SCC during the immediate postpartum period.

Mastitis is a major disease affecting dairy sheep. It is caused by microorganisms that generate inflammation of the mammary gland in response to tissue invasion. This syndrome affects the welfare of ewes, as well as the production and quality of the milk, thereby reducing its productive efficiency. Because mastitis causes inflammation process, it also increases the production of free radicals that cause lesions via lipoperoxidation, causing damage to proteins, cells and tissues. One way to minimize the impact of the disease is antimicrobial treatment. Nevertheless, the continuous use of antimicrobials contributes to microbial resistance, in addition to producing residues in the milk and derivatives if not given during the grace period. Therefore, the objective of this study was to evaluate the consequences of subclinical mastitis on ewe health, milk production, milk composition and quality. We also evaluated the susceptibility of the bacteria in vitro using disk diffusion antibiograms. Finally, we performed two-way testing of efficacy of treatment in Lacaune ewes using the same agents. In the first stage of the study, 30 lactating ewes (±90 days) were used, 10 of which were negative on the CMT (California Mastitis Test) used as control group (CG) and 20 sheep with subclinical mastitis diagnosed by CMT (MG). Samples were collected and several analyses were performed on the milk and blood. We found that ewes in the MG had higher lipid peroxidation in serum and milk, as well as lower production, with reduction of the total dry extract in milk. There were 15 isolates of Staphylococcus hyicus, four isolates of each S. epidermidis and S. intermedius, and two isolates of Corynebacterium spp. The primary hematological result was leukocytosis in ewes with mastitis. Based on the antibiogram, we chose ceftiofur for in vivo tests. In this stage, we divided the sheep with subclinical mastitis into two subgroups of 10 ewes each, to receive drug by two routes: intramuscular (IM) and intramammary (IMM). In the IMM group, of the 10 CMT-positive ewes at the beginning of the experiment, seven were already negative by the racket test 120 h after the last application (70% efficacy). In the IM group, of the 10 positive ewes, only four were negative after 120 h of the final application, a low efficacy treatment (40%). We evaluated antimicrobial residues in the milk of treated animals. We found this material within 5 days after treatment in the two forms used; despite the fact that the product's stated withholding period is 3 days. We conclude that ewes with mastitis produce less milk of lower quality. We also conclude that, although ceftiofur is 100% effective in vitro, when used in ewes with mastitis, the efficacy did not exceed 70%, and was more efficient when administered via the intramammary route.